Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eli lilly
fda
galcanezumab
2
×
indiana blog main
indiana top stories
lasmiditan
life sciences
migraine
2
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
2
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aimmune therapeutics
alder biopharmaceutical
allergan
alopecia areata
amarin
american academy of neurology
amgen
What
companies
approval
arena’s
arguments
big
bio
bounty
cig
class
comeback
commercialized
competitors
corner
deals
decades
delivered
drug
drugs
expressing
fda
ipo
life
little
make
meeting
migraine
moderna’s
neuro
new
number
oral
potential
roundup
science
survey
thanks
thanksgiving
therapies
week
won
Language
Current search:
galcanezumab
×
" san francisco top stories "
×
migraine
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More